| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,707 |
17,014 |
$833K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,705 |
17,756 |
$621K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,754 |
6,545 |
$497K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,478 |
5,080 |
$394K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,352 |
3,261 |
$263K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
18,973 |
17,596 |
$247K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
19,251 |
9,034 |
$246K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
23,545 |
9,710 |
$242K |
| 99429 |
|
5,325 |
5,219 |
$154K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,111 |
2,866 |
$124K |
| 87428 |
|
4,774 |
4,325 |
$114K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,909 |
8,487 |
$81K |
| 92558 |
|
9,357 |
9,106 |
$60K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
713 |
684 |
$60K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
588 |
557 |
$46K |
| 90461 |
|
7,765 |
6,529 |
$40K |
| 87807 |
|
3,820 |
3,598 |
$40K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,087 |
1,034 |
$34K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
278 |
265 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
569 |
554 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
72 |
69 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
428 |
411 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
157 |
147 |
$3K |
| 96160 |
|
1,194 |
1,155 |
$1K |
| 99382 |
|
12 |
12 |
$953.32 |
| 87634 |
|
13 |
13 |
$766.61 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
13 |
$184.38 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
14 |
$149.60 |
| 95117 |
|
16 |
14 |
$119.84 |
| 81002 |
|
44 |
39 |
$119.73 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
13 |
$10.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
13 |
$1.20 |
| 90671 |
|
663 |
597 |
$0.20 |
| 90677 |
|
753 |
667 |
$0.12 |
| 90686 |
|
3,025 |
2,978 |
$0.02 |
| 90744 |
|
666 |
649 |
$0.00 |
| 90647 |
|
837 |
816 |
$0.00 |
| 90698 |
|
2,948 |
2,874 |
$0.00 |
| 90723 |
|
478 |
470 |
$0.00 |
| 90651 |
|
13 |
13 |
$0.00 |
| 90381 |
|
21 |
13 |
$0.00 |
| 90696 |
|
48 |
28 |
$0.00 |
| 90670 |
|
2,425 |
2,348 |
$0.00 |
| 90633 |
|
993 |
959 |
$0.00 |
| 90710 |
|
657 |
596 |
$0.00 |
| 90681 |
|
652 |
637 |
$0.00 |
| 90734 |
|
13 |
13 |
$0.00 |